Lifeist Wellness Inc. (LFST.V)
CAD 0.05
(-10.0%)
CAD 0.05
(-10.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.51 Million CAD | -0.56% |
| 2022 | 4.53 Million CAD | -15.51% |
| 2021 | 5.36 Million CAD | -33.94% |
| 2020 | 8.12 Million CAD | 35.53% |
| 2019 | 5.99 Million CAD | 118.75% |
| 2018 | 2.74 Million CAD | 9.76% |
| 2017 | 2.49 Million CAD | 164.8% |
| 2016 | 943.3 Thousand CAD | 91.21% |
| 2015 | 493.33 Thousand CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.25 Million CAD | -32.21% |
| 2024 Q1 | 3.32 Million CAD | -26.22% |
| 2024 Q3 | 1.4 Million CAD | -37.55% |
| 2023 Q2 | 5.72 Million CAD | 36.67% |
| 2023 Q4 | 4.51 Million CAD | -19.47% |
| 2023 Q3 | 5.6 Million CAD | -2.08% |
| 2023 FY | 4.51 Million CAD | -0.56% |
| 2023 Q1 | 4.18 Million CAD | -7.74% |
| 2022 Q3 | 6.96 Million CAD | 7.82% |
| 2022 FY | 4.53 Million CAD | -15.51% |
| 2022 Q1 | 6.43 Million CAD | 19.86% |
| 2022 Q4 | 4.53 Million CAD | -34.85% |
| 2022 Q2 | 6.45 Million CAD | 0.35% |
| 2021 Q1 | 5.97 Million CAD | -26.48% |
| 2021 Q3 | 4.85 Million CAD | -6.69% |
| 2021 FY | 5.36 Million CAD | -33.94% |
| 2021 Q2 | 5.2 Million CAD | -12.98% |
| 2021 Q4 | 5.36 Million CAD | 10.65% |
| 2020 Q1 | 8.88 Million CAD | 48.21% |
| 2020 FY | 8.12 Million CAD | 35.53% |
| 2020 Q4 | 8.12 Million CAD | -3.75% |
| 2020 Q3 | 8.44 Million CAD | 6.92% |
| 2020 Q2 | 7.89 Million CAD | -11.13% |
| 2019 Q2 | 4.94 Million CAD | -28.85% |
| 2019 Q1 | 6.94 Million CAD | 20.4% |
| 2019 Q4 | 5.99 Million CAD | 18.91% |
| 2019 FY | 5.99 Million CAD | 118.75% |
| 2019 Q3 | 5.04 Million CAD | 2.08% |
| 2018 Q1 | 2.52 Million CAD | -10.56% |
| 2018 Q4 | 5.76 Million CAD | 110.38% |
| 2018 FY | 2.74 Million CAD | 9.76% |
| 2018 Q3 | 2.74 Million CAD | 14.86% |
| 2018 Q2 | 2.38 Million CAD | -5.57% |
| 2017 Q3 | 2.49 Million CAD | -14.19% |
| 2017 Q1 | 1.81 Million CAD | 33.85% |
| 2017 FY | 2.49 Million CAD | 164.8% |
| 2017 Q4 | 2.82 Million CAD | 13.14% |
| 2017 Q2 | 2.91 Million CAD | 60.19% |
| 2016 Q3 | 943.3 Thousand CAD | 74.27% |
| 2016 Q1 | 546.08 Thousand CAD | 24.41% |
| 2016 Q4 | 1.35 Million CAD | 43.92% |
| 2016 Q2 | 541.29 Thousand CAD | -0.88% |
| 2016 FY | 943.3 Thousand CAD | 91.21% |
| 2015 Q2 | 9074.00 CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | 493.33 Thousand CAD | 0.0% |
| 2015 Q4 | 438.92 Thousand CAD | -11.03% |
| 2015 Q3 | 493.33 Thousand CAD | 5336.8% |
| 2014 Q4 | - CAD | -100.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | 66.22 Thousand CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 123.74 Thousand CAD | -3545.501% |
| CanadaBis Capital Inc. | 5.82 Million CAD | 22.596% |
| Decibel Cannabis Company Inc. | 48.7 Million CAD | 90.738% |
| Delivra Health Brands Inc. | 1.47 Million CAD | -205.221% |
| Entourage Health Corp. | 10.01 Million CAD | 54.935% |
| Cannara Biotech Inc. | 33.77 Million CAD | 86.642% |
| Medicure Inc. | 2.9 Million CAD | -55.557% |
| PharmaCielo Ltd. | 2.31 Million CAD | -95.193% |
| Rubicon Organics Inc. | 11.27 Million CAD | 60.004% |
| BioSyent Inc. | 5.89 Million CAD | 23.468% |
| Voyageur Pharmaceuticals Ltd. | 10.32 Thousand CAD | -43600.107% |